Treatment In patients without hemophilia, cyclophosphamide, corticosteroids, or rituximab In patients with hemophilia, recombinant activated factor VII Therapy with cyclophosphamide, corticosteroids, or rituximab (monoclonal antibody to CD20 on lymphocytes) may suppress autoantibody production in patients without hemophilia (eg, in postpartum women).